U.S., Oct. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07891169) titled 'Master Protocol for Basket Clinical Trials of Targeted Therapies Based on Proteome and Whole Exome Sequencing Screening in Patients With Advanced Solid Tumors' on Oct. 07.
Brief Summary: Study Overview This study evaluates a proteogenomic screening platform to identify precise therapeutic targets for patients with advanced solid tumors. While traditional precision medicine relies on DNA sequencing (genomics), this research adds protein analysis (proteomics) to better understand how cancer cells function and respond to treatment.
1. Background and Purpose Standard genomic testing often fails to predict whether a patient will respond...